Advertisement

A Detective Story

Some infections are largely a thing of the past—plague, syphilis. The unfortunate result of these antibiotic-driven successes is the emergence of drug-resistant pathogens. And, ironically enough, hospitals are at the center of the problem. An example of this occurred in 2011 at the Clinical Center of the U.S. National Institutes of Health (NIH), in which an outbreak of drug-resistant Klebsiella pneumoniae infected 18 patients, causing the death of 6 of them. Using a combination of whole-genome sequencing and patient tracking, Snitkin and his colleagues examined how the bacteria was spreading through the hospital. The results outline a complicated path of transmission within the hospital that defied standard containment methods, yielding lessons for the future.
A patient known to be infected with a drug-resistant form of K. pneumoniae was admitted to the NIH Clinical Center on 13 June 2011. Enhanced isolation procedures were immediately implemented, and no spread of the bacteria was seen for the month she was in the hospital. Although all seemed well, a few weeks later on August 5th, a second infected patient was discovered, followed by a series of other patients with infection or colonization—about 1 a week to a total of 18 by the end of 2011. Six people ultimately died as a result of the bacteria. The outbreak was finally contained by rigorous control procedures.
A careful survey of the bed locations of each patient did not shed much light on how the bacteria traveled on its deadly path: The first patient did not even come into contact with any of the others. So the authors performed whole-genome sequencing on all of the bacteria that were found, determining the most likely evolutionary relationships among them by comparing the variations at single nucleotides that arise as bacteria grow. Combining this evolutionary information with the physical tracking of the patients pointed to the most likely transmission scenario.
The authors concluded that all of the K. pneumoniae cases likely originated with the index patient, from at least two different sites on her body, rather than by independently introduced bacteria. There were at least three different initial transmission events. Particularly disturbing was the fact that one of the infections could be linked to contamination of a ventilator that had been cleaned by thorough methods.
Sophisticated deployment of whole-genome sequencing revealed the weaknesses in this medical who-done-it, informing improvements in hospital preventive measures. If applied rapidly, such analysis can even expose the causes of nosocomial infections in real time.

Abstract

The Gram-negative bacteria Klebsiella pneumoniae is a major cause of nosocomial infections, primarily among immunocompromised patients. The emergence of strains resistant to carbapenems has left few treatment options, making infection containment critical. In 2011, the U.S. National Institutes of Health Clinical Center experienced an outbreak of carbapenem-resistant K. pneumoniae that affected 18 patients, 11 of whom died. Whole-genome sequencing was performed on K. pneumoniae isolates to gain insight into why the outbreak progressed despite early implementation of infection control procedures. Integrated genomic and epidemiological analysis traced the outbreak to three independent transmissions from a single patient who was discharged 3 weeks before the next case became clinically apparent. Additional genomic comparisons provided evidence for unexpected transmission routes, with subsequent mining of epidemiological data pointing to possible explanations for these transmissions. Our analysis demonstrates that integration of genomic and epidemiological data can yield actionable insights and facilitate the control of nosocomial transmission.
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Supplementary Material

Summary

Methods
Fig. S1. Repetitive element PCR and pulsed-field gels of representative outbreak isolates.
Fig. S2. Surveillance cultures for outbreak patients.
Fig. S3. Transmission opportunities between patients when using negative rectal surveillance to exclude patient colonization
Fig. S4. Predicted transmission chart based only on genetic data.
Fig. S5. Predicted transmission chart based only on epidemiological data.
Fig. S6. Computing epidemiological distances between patients.
Table S1. Genome sequencing statistics.
Table S2. Characteristics of patients who acquired outbreak strain.
Table S3. MICs for antibiotic susceptibility of outbreak isolates.
Table S4. Mutations identified among outbreak genomes.

Resources

File (4-148ra116_sm.pdf)

References and Notes

1
Lockhart S. R., Abramson M. A., Beekmann S. E., Gallagher G., Riedel S., Diekema D. J., Quinn J. P., Doern G. V., Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45, 3352–3359 (2007).
2
Montgomerie J. Z., Epidemiology of Klebsiella and hospital-associated infections. Rev. Infect. Dis. 1, 736–753 (1979).
3
Yigit H., Queenan A. M., Anderson G. J., Domenech-Sanchez A., Biddle J. W., Steward C. D., Alberti S., Bush K., Tenover F. C., Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45, 1151–1161 (2001).
4
Nordmann P., Cuzon G., Naas T., The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9, 228–236 (2009).
5
Gupta N., Limbago B. M., Patel J. B., Kallen A. J., Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53, 60–67 (2011).
6
Hirsch E. B., Tam V. H., Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): An emerging cause of multidrug-resistant infection. J. Antimicrob. Chemother. 65, 1119–1125 (2010).
7
Livermore D. M., Warner M., Mushtaq S., Doumith M., Zhang J., Woodford N., What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int. J. Antimicrob. Agents 37, 415–419 (2011).
8
Patel G., Huprikar S., Factor S. H., Jenkins S. G., Calfee D. P., Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29, 1099–1106 (2008).
9
Ben-David D., Kordevani R., Keller N., Tal I., Marzel A., Gal-Mor O., Maor Y., Rahav G., Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin. Microbiol. Infect. 18, 54–60 (2012).
10
Bush K., Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13, 558–564 (2010).
11
Asensio A., Oliver A., González-Diego P., Baquero F., Pérez-Díaz J. C., Ros P., Cobo J., Palacios M., Lasheras D., Cantón R., Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection. Clin. Infect. Dis. 30, 55–60 (2000).
12
Peña C., Pujol M., Ardanuy C., Ricart A., Pallares R., Liñares J., Ariza J., Gudiol F., Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42, 53–58 (1998).
13
Jarvis W. R., Munn V. P., Highsmith A. K., Culver D. H., Hughes J. M., The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect. Control 6, 68–74 (1985).
14
Selden R., Lee S., Wang W. L. L., Bennet J. V., Eickhoff T. C., Nosocomial Klebsiella infections: Intestinal colonization as a reservoir. Ann. Intern. Med. 74, 657–664 (1971).
15
Casewell M., Phillips I., Hands as route of transmission for Klebsiella species. Br. Med. J. 2, 1315–1317 (1977).
16
Kitchel B., Rasheed J. K., Patel J. B., Srinivasan A., Navon-Venezia S., Carmeli Y., Brolund A., Giske C. G., Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: Clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53, 3365–3370 (2009).
17
Diancourt L., Passet V., Verhoef J., Grimont P. A. D., Brisse S., Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43, 4178–4182 (2005).
18
Won S. Y., Munoz-Price L. S., Lolans K., Hota B., Weinstein R. A., Hayden M. K.; Centers for Disease Control and Prevention Epicenter Program, Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae. Clin. Infect. Dis. 53, 532–540 (2011).
19
Parkhill J., Wren B. W., Bacterial epidemiology and biology—Lessons from genome sequencing. Genome Biol. 12, 230 (2011).
20
Pallen M. J., Loman N. J., Are diagnostic and public health bacteriology ready to become branches of genomic medicine? Genome Med. 3, 53 (2011).
21
Harris S. R., Feil E. J., Holden M. T. G., Quail M. A., Nickerson E. K., Chantratita N., Gardete S., Tavares A., Day N., Lindsay J. A., Edgeworth J. D., de Lencastre H., Parkhill J., Peacock S. J., Bentley S. D., Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469–474 (2010).
22
Mutreja A., Kim D. W., Thomson N. R., Connor T. R., Lee J. H., Kariuki S., Croucher N. J., Choi S. Y., Harris S. R., Lebens M., Niyogi S. K., Kim E. J., Ramamurthy T., Chun J., Wood J. L. N., Clemens J. D., Czerkinsky C., Nair G. B., Holmgren J., Parkhill J., Dougan G., Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477, 462–465 (2011).
23
Beres S. B., Carroll R. K., Shea P. R., Sitkiewicz I., Martinez-Gutierrez J. C., Low D. E., McGeer A., Willey B. M., Green K., Tyrrell G. J., Goldman T. D., Feldgarden M., Birren B. W., Fofanov Y., Boos J., Wheaton W. D., Honisch C., Musser J. M., Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics. Proc. Natl. Acad. Sci. U.S.A. 107, 4371–4376 (2010).
24
Chin C. S., Sorenson J., Harris J. B., Robins W. P., Charles R. C., Jean-Charles R. R., Bullard J., Webster D. R., Kasarskis A., Peluso P., Paxinos E. E., Yamaichi Y., Calderwood S. B., Mekalanos J. J., Schadt E. E., Waldor M. K., The origin of the Haitian cholera outbreak strain. N. Engl. J. Med. 364, 33–42 (2011).
25
Gardy J. L., Johnston J. C., Ho Sui S. J., Cook V. J., Shah L., Brodkin E., Rempel S., Moore R., Zhao Y., Holt R., Varhol R., Birol I., Lem M., Sharma M. K., Elwood K., Jones S. J. M., Brinkman F. S. L., Brunham R. C., Tang P., Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 364, 730–739 (2011).
26
Lienau E. K., Strain E., Wang C., Zheng J., Ottesen A. R., Keys C. E., Hammack T. S., Musser S. M., Brown E. W., Allard M. W., Cao G., Meng J., Stones R., Identification of a salmonellosis outbreak by means of molecular sequencing. N. Engl. J. Med. 364, 981–982 (2011).
27
Rasko D. A., Webster D. R., Sahl J. W., Bashir A., Boisen N., Scheutz F., Paxinos E. E., Sebra R., Chin C. S., Iliopoulos D., Klammer A., Peluso P., Lee L., Kislyuk A. O., Bullard J., Kasarskis A., Wang S., Eid J., Rank D., Redman J. C., Steyert S. R., Frimodt-Møller J., Struve C., Petersen A. M., Krogfelt K. A., Nataro J. P., Schadt E. E., Waldor M. K., Origins of the E. coli strain causing an outbreak of hemolytic–uremic syndrome in Germany. N. Engl. J. Med. 365, 709–717 (2011).
28
Rasko D. A., Worsham P. L., Abshire T. G., Stanley S. T., Bannan J. D., Wilson M. R., Langham R. J., Decker R. S., Jiang L., Read T. D., Phillippy A. M., Salzberg S. L., Pop M., Van Ert M. N., Kenefic L. J., Keim P. S., Fraser-Liggett C. M., Ravel J., Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proc. Natl. Acad. Sci. U.S.A. 108, 5027–5032 (2011).
29
Eyre D. W., Golubchik T., Gordon N. C., Bowden R., Piazza P., Batty E. M., Ip C. L. C., Wilson D. J., Didelot X., O’Connor L., Lay R., Buck D., Kearns A. M., Shaw A., Paul J., Wilcox M. H., Donnelly P. J., Peto T. E. A., Walker A. S., Crook D. W., A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open 2, e001124 (2012).
30
Lieberman T. D., Michel J. B., Aingaran M., Potter-Bynoe G., Roux D., Davis M. R., Skurnik D., Leiby N., LiPuma J. J., Goldberg J. B., McAdam A. J., Priebe G. P., Kishony R., Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genet. 43, 1275–1280 (2011).
31
Köser C. U., Holden M. T. G., Ellington M. J., Cartwright E. J. P., Brown N. M., Ogilvy-Stuart A. L., Hsu L. Y., Chewapreecha C., Croucher N. J., Harris S. R., Sanders M., Enright M. C., Dougan G., Bentley S. D., Parkhill J., Fraser L. J., Betley J. R., Schulz-Trieglaff O. B., Smith G. P., Peacock S. J., Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N. Engl. J. Med. 366, 2267–2275 (2012).
32
Lewis T., Loman N. J., Bingle L., Jumaa P., Weinstock G. M., Mortiboy D., Pallen M. J., High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J. Hosp. Infect. 75, 37–41 (2010).
33
Pränting M., Negrea A., Rhen M., Andersson D. I., Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar typhimurium LT2. Antimicrob. Agents Chemother. 52, 2734–2741 (2008).
34
Mattiuzzo M., Bandiera A., Gennaro R., Benincasa M., Pacor S., Antcheva N., Scocchi M., Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol. Microbiol. 66, 151–163 (2007).
35
Feero W. G., Guttmacher A. E., Collins F. S., Genomic medicine—An updated primer. N. Engl. J. Med. 362, 2001–2011 (2010).
36
Comas I., Borrell S., Roetzer A., Rose G., Malla B., Kato-Maeda M., Galagan J., Niemann S., Gagneux S., Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106–110 (2011).
37
Arias C. A., Panesso D., McGrath D. M., Qin X., Mojica M. F., Miller C., Diaz L., Tran T. T., Rincon S., Barbu E. M., Reyes J., Roh J. H., Lobos E., Sodergren E., Pasqualini R., Arap W., Quinn J. P., Shamoo Y., Murray B. E., Weinstock G. M., Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl. J. Med. 365, 892–900 (2011).
38
Otter J. A., Yezli S., Schouten M. A., van Zanten A. R. H., Houmes-Zielman G., Nohlmans-Paulssen M. K. E., Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak. Am. J. Infect. Control 38, 754–756 (2010).
39
Palmore T. N., Michelin A. V., Bordner M., Odom R. T., Stock F., Sinaii N., Fedorko D. P., Murray P. R., Henderson D. K., Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital. Infect. Control Hosp. Epidemiol. 32, 1166–1172 (2011).
40
Rissman A. I., Mau B., Biehl B. S., Darling A. E., Glasner J. D., Perna N. T., Reordering contigs of draft genomes using the Mauve aligner. Bioinformatics 25, 2071–2073 (2009).
41
Darling A. C., Mau B., Blattner F. R., Perna N. T., Mauve: Multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14, 1394–1403 (2004).
42
Jombart T., Eggo R. M., Dodd P. J., Balloux F., Reconstructing disease outbreaks from genetic data: A graph approach. Heredity 106, 383–390 (2011).
43
Wiener-Well Y., Rudensky B., Yinnon A. M., Kopuit P., Schlesinger Y., Broide E., Lachish T., Raveh D., Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J. Hosp. Infect. 74, 344–349 (2010).
44
Fouts D. E., Phage_Finder: Automated identification and classification of prophage regions in complete bacterial genome sequences. Nucleic Acids Res. 34, 5839–5851 (2006).
45
Delcher A. L., Phillippy A., Carlton J., Salzberg S. L., Fast algorithms for large-scale genome alignment and comparison. Nucleic Acids Res. 30, 2478–2483 (2002).
46
Edmonds J., Optimum branchings. J. Res. Natl. Bur. Standards 9, 233–240 (1967).

Information & Authors

Information

Published In

Science Translational Medicine
Volume 4 | Issue 148
August 2012

Submission history

Received: 10 April 2012
Accepted: 30 July 2012

Permissions

Request permissions for this article.

Acknowledgments

We thank S. Holland, P. Murray, F. Candotti, and H. Kong for their thoughtful discussions and advice, and T. Connor and J. Parkhill for sharing unpublished sequence data. Funding: Supported by the National Human Genome Research Institute and NIH Clinical Center Intramural Research Programs and by an NIH Director’s Challenge Award for genome sequencing. E.S.S. is supported by a Pharmacology Research Associate Training Fellowship, National Institute of General Medical Sciences. Author contributions: E.S.S., A.M.Z., D.K.H., T.N.P., and J.A.S. conceived the study. NISC performed genome sequencing. P.J.T. performed bioinformatics annotation and coordinated sequencing studies. F.S. performed repetitive PCR and pulsed-field gel electrophoresis. E.S.S. performed all data analysis. E.S.S., D.K.H., T.N.P., and J.A.S. wrote the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: The results of the Whole Genome Shotgun project have been deposited at DNA Database of Japan/European Molecular Biology Laboratory/GenBank under accession numbers AJZU00000000, AJZV00000000, AJZW00000000, AJZX00000000, AJZY00000000, AJZZ00000000, AKAA00000000, AKAB00000000, AKAC00000000, AKAD00000000, AKAE00000000, AKAF00000000, AKAG00000000, AKAH00000000, AKAI00000000, AKAJ00000000, AKAK00000000, AKAL00000000, AKAM00000000, and AKAN00000000.

Authors

Affiliations

Evan S. Snitkin
National Human Genome Research Institute, Bethesda, MD 20892, USA.
Adrian M. Zelazny
National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
Pamela J. Thomas
National Human Genome Research Institute, Bethesda, MD 20892, USA.
Frida Stock
National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
NISC Comparative Sequencing Program
National Institutes of Health Intramural Sequencing Center (NISC), Bethesda, MD 20892, USA.
David K. Henderson
National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
Tara N. Palmore* [email protected]
National Institutes of Health Clinical Center, Bethesda, MD 20892, USA.
Julia A. Segre* [email protected]
National Human Genome Research Institute, Bethesda, MD 20892, USA.

Notes

*To whom correspondence should be addressed. E-mail: [email protected] (T.N.P.); [email protected] (J.A.S.)

Metrics & Citations

Metrics

Article Usage
Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. The Next Big Thing? Next-Generation Sequencing of Microbial Cell-Free DNA Using the Karius Test, Clinical Microbiology Newsletter, 43, 9, (69-79), (2021).https://doi.org/10.1016/j.clinmicnews.2021.04.003
    Crossref
  2. Outbreaks in Health Care Settings, Infectious Disease Clinics of North America, 35, 3, (631-666), (2021).https://doi.org/10.1016/j.idc.2021.04.006
    Crossref
  3. mSphere of Influence: Whole-Genome Sequencing, a Vital Tool for the Interruption of Nosocomial Transmission, mSphere, 6, 2, (2021).https://doi.org/10.1128/mSphere.00230-21
    Crossref
  4. Learner-centric Design of a Hand Hygiene Serious Simulation Game for Grade 12 Emerging Health Professional Students, TechTrends, 65, 3, (379-393), (2021).https://doi.org/10.1007/s11528-020-00577-2
    Crossref
  5. Hospital Epidemiology and Infection Control in the Transplant Center, Emerging Transplant Infections, (99-130), (2021).https://doi.org/10.1007/978-3-030-25869-6
    Crossref
  6. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258, mBio, 12, 1, (2021).https://doi.org/10.1128/mBio.00034-21
    Crossref
  7. Emerging carbapenem-resistant Klebsiella pneumoniae sequence type 16 causing multiple outbreaks in a tertiary hospital in southern Vietnam, Microbial Genomics, 7, 3, (2021).https://doi.org/10.1099/mgen.0.000519
    Crossref
  8. Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients, Nature Microbiology, 6, 5, (606-616), (2021).https://doi.org/10.1038/s41564-021-00879-y
    Crossref
  9. Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated Clostridioides difficile and carbapenem-resistant Klebsiella pneumoniae infections: a scoping review , BMJ Open, 11, 8, (e051983), (2021).https://doi.org/10.1136/bmjopen-2021-051983
    Crossref
  10. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility, Nature Medicine, 27, 8, (1401-1409), (2021).https://doi.org/10.1038/s41591-021-01383-w
    Crossref
  11. See more
Loading...

View Options

Get Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share